Terminology Service < Semantic Lookup Platform

All terms in EFO

Label	Id	Description
ILSXISS60/TejJ	EFO_0003020
obsolete_West syndrome	Orphanet_3451
RNA-seq of non coding RNA from single cells	EFO_0005685	[An assay in which sequencing technology (e.g. Illumina) is used to generate RNA sequence, from the presumed non-coding transcibed regions of the genome, or analyse these or to quantitate transcript abundance in individual cells instead of a population of cells.]
interferon alpha 2a	EFO_0003022
obsolete_Weissenbacher- Zweymuller syndrome	Orphanet_3450
interferon alpha	EFO_0003021
receptive language perception	EFO_0005686	[Receptive language means the ability to understand or comprehend language heard or read]
obsolete_plant callus	EFO_0005683	[A portion of plant tissue that consists of mass of undifferentiated plant cells. Consists primarily of parenchyma cells but may contain other cell types as the callus begins to differentiate. May be formed as a result of wounding or may develop in culture.]
interferon gamma	EFO_0003024
RNA-seq of coding RNA from single cells	EFO_0005684	[An assay in which sequencing technology (e.g. Illumina) is used to generate RNA sequence, from the presumed coding transcibed regions of the genome, or analyse these or to quantitate transcript abundance in individual cells instead of a population of cells.]
interferon beta	EFO_0003023
autoimmune disease of ear, nose and throat	MONDO_0000587	[An autoimmune form of otorhinolaryngologic disease.]
non-high density lipoprotein cholesterol measurement	EFO_0005689	[The quantification of NHDL cholesterol in blood, calculated by subtracting the amount of cholesterol in the HDL fraction from total cholesterol and used as an indicator for cardiovascular disease risk]
NHDL cholesterol	EFO_0005688	[non-high-density lipoprotein cholesterol (NHDL), calculated by subtracting the amount of cholesterol in the HDL fraction from total cholesterol, quantifies almost all potentially atherogenic apolipoprotein B containing lipoproteins encompassing cholesterol bound to low-density lipoproteins (LDL), very low-density lipoproteins, intermediate-density lipoproteins, lipoprotein(a), chylomicrons, and chylomicron remnants]
minimally differentiated acute myeloblastic leukemia	EFO_0003026	[An acute myeloid leukemia (AML) in which the blasts do not show evidence of myeloid differentiation by morphology and conventional cytochemistry. (WHO, 2001)]
acute megakaryoblastic leukaemia	EFO_0003025	[Acute megakaryoblastic leukemia (AMKL) is a form of acute myeloid leukemia (AML) that occurs predominantly in childhood and particularly in children with Down syndrome (DS-AMKL). Nonspecific symptoms may be irritability, weakness, and dizziness while specific symptoms include pallor, fever, mucocutaneous bleeding, hepatosplenomegaly, neurological manifestations and rarely lymphadenopathy. Acute panmyelosis with myelofibrosis may also be associated with AMKL. In contrast to DS-AMKL (around 80 % survival), non-DS-AMKL is an AML subgroup associated with poor prognosis.]
fibromyalgia	EFO_0005687	[A chronic disorder of unknown etiology characterized by pain, stiffness, and tenderness in the muscles of neck, shoulders, back, hips, arms, and legs. Other signs and symptoms include headaches, fatigue, sleep disturbances, and painful menstruation.]
acute myeloblastic leukemia with maturation	EFO_0003028	[An acute myeloid leukemia (AML) characterized by blasts with evidence of maturation to more mature neutrophils. (WHO, 2001)]
primary immunodeficiency syndrome due to p14 deficiency	MONDO_0012559	[Primary immunodeficiency syndrome due to p14 deficiency is characterised by short stature, hypopigmentation, coarse facies and frequent bronchopulmonary Streptococcus pneumoniae infections.]
acute myeloblastic leukemia without maturation	EFO_0003027	[An acute myeloid leukemia (AML) characterized by blasts without evidence of maturation to more mature neutrophils. (WHO, 2001)]